Stockscreener 앱 받기
132.66
0.98%
1.29
시간 외 거래:
132.66
Abbott Laboratories 주식(ABT)의 최신 뉴스
Tools to assess Abbott Laboratories’s risk profileQuarterly Growth Report & Consistent Profit Trading Strategies - Newser
Is now a turning point for Abbott Laboratories2025 Risk Factors & Expert Curated Trade Setups - Newser
How Is Abbott Laboratories' Stock Performance Compared to Other Medical Devices Stocks? - MSN
Is Abbott Laboratories stock undervalued right nowQuarterly Profit Review & Expert Curated Trade Setup Alerts - خودرو بانک
Abbott Laboratories stock trend outlook and recovery pathQuarterly Performance Summary & AI Powered Buy and Sell Recommendations - Newser
How to integrate Abbott Laboratories into portfolio analysis toolsWeekly Trend Report & Low Drawdown Momentum Ideas - Newser
Measuring Abbott Laboratories’s beta against major indicesWeekly Investment Report & Weekly Hot Stock Watchlists - Newser
What earnings revisions data tells us about Abbott LaboratoriesJuly 2025 Update & Consistent Profit Alerts - Newser
Price action breakdown for Abbott LaboratoriesShort Setup & AI Powered Market Trend Analysis - Newser
Abbott Laboratories Shows Early Signs of Technical Strength getLinesFromResByArray error: size == 0 - thegnnews.com
Jim Cramer Shares Little Known Potential Catalyst For Abbott Laboratories (ABT) - MSN
Does Abbott Laboratories fit your quant trading modelWeekly Trend Summary & Low Risk High Win Rate Stock Picks - Newser
Real time pattern detection on Abbott Laboratories stockJuly 2025 Trends & Fast Gaining Stock Strategy Reports - Newser
What institutional flow reveals about Abbott LaboratoriesMarket Activity Report & Reliable Volume Spike Alerts - Newser
What MACD and RSI say about Abbott LaboratoriesJuly 2025 Spike Watch & Weekly Setup with High ROI Potential - Newser
Abbott Laboratories CEO warns tariffs are here to stay, points to new US investments [Video] - AOL.com
Precision Trading with Abbott Laboratories (ABT) Risk Zones - news.stocktradersdaily.com
A Look at Abbott Laboratories’s Valuation Following Strong Medical Device Launches and Regulatory Milestones - simplywall.st
Abbott’s Possible Pokeno Acquisition Might Change the Case for Investing in Abbott Laboratories (ABT) - Yahoo Finance
Ranking Abbott Laboratories among high performing stocks via toolsPortfolio Update Report & Free Risk Controlled Daily Trade Plans - Newser
Price momentum metrics for Abbott Laboratories explainedJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - Newser
Stock Analysis | Abbott Laboratories OutlookNavigating Mixed Signals in a Volatile Market - AInvest
IoT in Healthcare Market to See Thriving Worldwide | Abbott Laboratories, Philips, Medtronic - openPR.com
Can a trend reversal in Abbott Laboratories lead to recoveryJuly 2025 Trends & Low Risk Profit Maximizing Plans - Newser
St. Jude Medical delivers sales growth for Abbott Labs - Star Tribune
Abbott Laboratories: Is The Growth in Continuous Glucose Monitoring (CGM) & Ketone Monitoring Here To Stay? - Smartkarma
Applying chart zones and confluence areas to Abbott Laboratories2025 Institutional Moves & Weekly High Potential Alerts - Newser
Live market analysis of Abbott Laboratories2025 Price Action Summary & Comprehensive Market Scan Insights - Newser
Abbott Laboratories Severance Pay: Your Rights Explained - Samfiru Tumarkin LLP
Abbott receives expanded approval for Navitor TAVR system - Cardiovascular Business
Does Abbott Laboratories show high probability of reboundBond Market & Entry Point Confirmation Signals - Newser
ABT vs. EW: Which Structural Heart Device Stock Is Worth Buying Now? - The Globe and Mail
Is Abbott Laboratories stock poised for growthBuy Signal & Consistent Return Investment Signals - Newser
How Abbott Laboratories (ABT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Abbott gets EU CE Mark for expanded use of Navitor TAVI system - Seeking Alpha
Abbott Laboratories Receives CE Mark for Expanded Indication for Navitor Aortic Valve Implant - MarketScreener
Major Breakthrough: Abbott's Navitor Heart Valve Now Approved for All Surgical Risk Levels in Europe - Stock Titan
Abbott Laboratories stock chart pattern explained2025 Big Picture & Low Risk Entry Point Tips - Newser
What makes Abbott Laboratories stock price move sharplyJuly 2025 Short Interest & Capital Efficiency Focused Strategies - Newser
Formula makers have been hiding the truth — and endangering the tiniest babies | Opinion - The Tennessean
Can machine learning forecast Abbott Laboratories recoveryJuly 2025 Trends & Community Verified Trade Signals - Newser
Abbott wins expanded CE mark for Navitor TAVI system, reports updated TEER guidelines - MassDevice
0.24%
0.45%
자본화:
|
볼륨(24시간):